Lydian Clinic Announces Stem Cell Therapy for Orthopedic Conditions In Gangnam

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Lydian Cosmetic Surgery Clinic now offers orthopedic stem cell therapy consultations in Gangnam for adults exploring non-surgical treatment options for selected joint and orthopedic conditions.

-- SEOUL, South Korea - August 31, 2026 - As treatment options for orthopedic conditions continue to evolve, more patients are evaluating non-surgical approaches alongside conventional care before deciding on their next step. In response, Lydian Cosmetic Surgery Clinic has announced orthopedic stem cell therapy consultations in Gangnam, providing patients with an opportunity to learn whether regenerative treatment may be appropriate for their condition following clinical evaluation.

Interest in regenerative therapies continues to grow as aging populations, active adults recovering from orthopedic injuries, and patients exploring alternatives to joint replacement seek information about emerging treatment approaches. While surgery remains appropriate in many situations, regenerative medicine continues to be an area of clinical research for selected orthopedic conditions, particularly where conventional approaches have not provided sufficient relief.

One area receiving particular attention is autologous stem cell therapy, which uses a patient's own cells, including mesenchymal stem cells that may be harvested from sources such as bone marrow or adipose tissue. Depending on the treatment protocol, cells can be processed before being reinjected into the affected area. Researchers continue to investigate how these approaches may be used in regenerative medicine and which patients may benefit from them.

"Stem cell therapy continues to be an evolving area of orthopedic medicine," said Dr. Abraham An of Lydian Cosmetic Surgery Clinic. "Every patient's condition is different, so careful evaluation is essential to determine whether regenerative treatment is an appropriate option and to ensure patients understand both the potential benefits and the current evidence."

For patients who may be suitable candidates following evaluation, Lydian Clinic performs stem cell extraction, processing, and reinjection within its regenerative medicine facility in Gangnam. The clinic's Class 10,000 sterile laboratory is designed to support controlled cell-processing procedures within the same facility, while treatment protocols are developed according to each patient's clinical circumstances.

The clinic's approach emphasizes individual evaluation before treatment. Patients can discuss their orthopedic condition, medical history, previous treatments, and potential regenerative options during a consultation before determining whether stem cell therapy is appropriate.

Founded on nearly two decades of regenerative medicine research, Lydian Cosmetic Surgery Clinic provides stem cell therapies alongside cosmetic and anti-aging treatments under the direction of Dr. Abraham An. The clinic serves patients from South Korea and abroad seeking personalized regenerative and aesthetic care.

For additional information about Lydian's orthopedic stem cell therapy consultations, visit Lydian's orthopedic stem cell therapy information page.

About Lydian Cosmetic Surgery Clinic

Lydian Cosmetic Surgery Clinic is a Gangnam-based medical clinic providing regenerative medicine, cosmetic procedures, and anti-aging treatments. Under the direction of Dr. Abraham An, the clinic offers personalized treatment consultations for patients from South Korea and abroad.

For more information, visit https://www.lydianclinic.com/

Contact Info:
Name: Dr. Abraham An
Email: Send Email
Organization: Lydian Cosmetic Surgery Clinic
Address: 836 Nonhyeon-ro, Sinsa-dong, Gangnam, Seoul, Seoul 06025, Korea, Republic of
Website: https://www.lydianclinic.com/

Source: NewsNetwork

Release ID: 89202597

In the event of any inaccuracies, problems, or queries arising from the content shared in this press release, we encourage you to notify us immediately at error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our diligent team will be readily available to respond and take swift action within 8 hours to rectify any identified issues or assist with removal requests. Ensuring the provision of high-quality and precise information is paramount to us.

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  252.40
-4.57 (-1.78%)
AAPL  315.34
-0.88 (-0.28%)
AMD  521.10
+15.36 (3.04%)
BAC  62.67
+0.28 (0.45%)
GOOG  328.38
-7.00 (-2.09%)
META  653.69
+40.21 (6.55%)
MSFT  491.65
-2.30 (-0.47%)
NVDA  223.67
-2.06 (-0.91%)
ORCL  161.63
-0.89 (-0.55%)
TSLA  367.81
-0.35 (-0.10%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.